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Objective: Short term effects of acupuncture treatment for hot flashes (HF) in breast cancer patients have been
demonstrated in several studies, including a randomized controlled trial, by the present authors. Results for the first
59 Tamoxifen medicated women receiving a 10 week course of acupuncture treatment have already been
published. A significant reduction in the number of hot flashes was demonstrated both day and night, for up to
three months following treatment in the women receiving traditional Chinese acupuncture. The control group
receiving sham (minimal acupuncture) demonstrated a HF reduction only at night during treatment, however the
effect did not remain significant during the following 12 weeks. The study was continued in order to investigate
longer term effects of acupuncture treatment, and patient’s quality of life two years after treatment.
Methods and materials: Eighty patients, who had 2 years previously been randomized to either a course of
15 acupuncture treatments or sham acupuncture (control) over a period of 10 weeks, were asked to fill out a
Kupperman index (KI) indicating health related quality of life.
Results: Sixty one women returned KI questionnaires. A mixed models procedure with diagonal covariance matrix
was used for statistical analyses. Baseline values between the sham-group and acupuncture group were not
significantly different. However scores at the end of treatment and after 3 months showed a statistically significant
difference between the groups, this difference lost its significance when scores were analyzed after 2 years.
Conclusion: Acupuncture seems to have a positive effect on health related quality of life for up three months
post-treatment, this study suggests that these effects may be longer-term, however there was no significant effect
2 years later.
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As treatment of breast cancer becomes increasingly
effective, more women are living with side effects due to
postoperative interventions affecting their quality of life
(Kronenberg 1994; Hervik and Mjåland 2010; Carpenter
et al. 2002). Women with breast cancer may undergo
years of post-operative treatments including endocrine
therapy, affecting their daily lives.
Breast cancer is the most frequently diagnosed cancer
and the leading cause of cancer death among females,
with over 1 million new diagnoses of breast cancer an-
nually worldwide, 55% of these are estrogen-receptor* Correspondence: jill.hervik@siv.no
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reproduction in any medium, provided the origpositive (ER+) (Boyle and Levin 2008). In accordance with
European guidelines medication with estrogen antagonists
is recommended for a minimum of five years for women
with ER+ tumors (Perry et al. 2008).
Hormone therapy medication includes the estrogen
antagonist Tamoxifen, and aromatsase inhibitors such as
Arimidex, Aromasin and Femara. Seventy-eight percent
of women taking Tamoxifen reported hot flashes as a
side effect, and 52% reported night sweats in a survey
investigating the prevalence of menopausal symptoms in
women with breast cancer (Walker et al. 2010). Hot
flashes (HF) are considered to be the most bothersome
side-effect of estrogen antagonist treatment, and are often
accompanied by sweating, palpitations, dizziness, nausea
and chills. Women treated with estrogen antagonists oftenThis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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insomnia and irritability.
Hot flashes are associated with peripheral blood vessel
dilation causing an increased skin temperature and
sweating. It has been suggested that HF are trigged by
small increases in core body temperature. Freedman
and Subramanian have demonstrated that vasomotor
instability, encountered by women with estrogen with-
drawal is due to a reduced hypothalamic thermoregula-
tory zone, compared to women without HF (Freedman
and Subramanian 2005). Sweating and heat symptoms
present if the upper threshold is crossed, and chills if
the core temperature falls below the lower threshold.
Reduced concentrations of β endorphins and serotonin,
and an increased release of noradrenalin are associated with
a fall in estrogen levels affecting the thermoregulatory set
point, thereby causing vasomotor instability. Based on this
theory, any intervention increasing levels of β endorphins
and serotonin, and reducing noradrenalin could be ex-
pected to reduce HF. Although the physiological effects of
acupuncture are still being investigated, research has indi-
cated that the autonomic nervous system is affected, influ-
encing neuropeptides such as β endorphins, serotonin, and
cytokines (Spetz Holm et al. 2012); thereby indicating that
acupuncture has the potential to influence the thermo-
regulatory centre.
Several recent randomized controlled trials have dem-
onstrated that acupuncture may be effective for managing
HF in breast cancer patients for up to 3 months post
treatment (Hervik and Mjaland 2009; Deng et al. 2007;
Nedstrand et al. 2005; Bokmand and Flyger 2013). How-
ever there is a distinct absence of randomized studies
investigating long term effect. Frisk compared electro-
acupuncture with HRT in a study including 45 women,
demonstrating long-term reduction in HF 24 months after
the start of treatment (Frisk et al. 2008). Flishie’s retro-
spective audit of treatment records of 182 women with
breast cancer suggests long term relief of HF from one
month to 6 years (mean 9 months) using acupuncture and
self acupuncture (Filshie et al. 2006). Recently de Valois
conducted a single arm study demonstrating a reduction
in HF for up to 18 weeks after the last of 8 treatments in
50 patients (Valois et al. 2010). The authors of this paper
have in a qualitative study demonstrated that women with
breast cancer were less bothered by hot flashes, and had a
more optimistic outlook on life, 2 years after acupuncture
treatment compared to those treated with sham acupunc-
ture (Hervik and Mjåland 2010). Quantitative studies in-
vestigating long-term effect of acupuncture for the relief
of HF in this patient category are lacking.
The purpose of this study was to measure the long term
effects of acupuncture two years after a 10 week course of
treatment, in women with breast cancer included in a ran-
domized controlled trial.Materials and methods
Background
The authors of this study have previously carried out a
randomized, controlled trial, investigating the effects of
acupuncture treatment in 88 breast cancer operated pa-
tients, medicated with the estrogen antagonist Tamoxifen,
complaining of hot flashes. Preliminary results for the first
59 women initially included have been published (Hervik
and Mjaland 2009). All participants had been medicated
with Tamoxifen for at least 3 months before starting treat-
ment, and were postmenopausal. Exclusion criteria inclu-
ded: those taking medication for hot flashes, previous
acupuncture, simultaneous treatment with other comple-
mentary or alternative therapies, and serious systemic or
psychological disorders. No hot flash severity limits were
implemented. Patients were randomized to either trad-
itional Chinese acupuncture (n = 43) or sham acupuncture
(n = 45), 15 treatments were administered over a 10 week
period. Patients were monitored during the treatment
period and for a further 12 weeks post-treatment.
The qualitative effect of acupuncture treatment be-
yond 3 months was later investigated. Qualitative infor-
mation was collected from patients included in the study
two years post treatment (Hervik and Mjåland 2010).
Written statements in response to the question, “would
you like to share your thoughts and experiences related
to your breast cancer diagnosis, treatments or anything
else?” were analyzed using systematic text condensation.
Most women reported being troubled by two or more
side-effects due to anti-estrogen medication, negatively
affecting their life quality. Symptoms included hot flashes,
sleep problems, muscle and joint pain, arm edema, fatigue,
weight gain, depression, and lack of sexual desire. Women
previously treated with sham acupuncture complained
that hot flashes were still problematic, whilst those previ-
ously treated with traditional Chinese acupuncture found
them less of a problem and generally had a more positive
outlook on life.
Patients
Our sample when investigating long-term follow up at
24 months was taken from the initial 59 women originally
included in the trial, and a further 29 patients included at
a later date. These 29 women were comparable to the
women originally included, in all aspects. Baseline values
of mean numbers of hot flashes at day and night, and total
KI score, measuring health related quality of life, were not
significantly different. Patients were treated and followed
up in an identical manner to those included originally.
Eight patients had died two years post treatment, a total
of 80 patients therefore received an invitation to take part
and a Kupperman index questionnaire in the post, 2 years
(+/− 2 months) after finishing the course of acupuncture
treatments. Thirty-nine patients had previously received
Table 1 Mean KI scores for groups 1 and 2 at time
intervals (a)
Group F Time Mean Std.
error
df 95% confidence interval
Lower bound Upper bound
1 1 15.767 .688 88 14.399 17.136
2 8.372 .649 88.000 7.081 9.663
3 10.023 .656 88.000 8.719 11.327
4 11.742 .925 59 9.890 13.594
2 1 13.422 .673 86 12.084 14.760
2 11.711 .635 88.000 10.449 12.973
3 13.689 .641 88.000 12.414 14.963
4 12.300 .941 59 10.418 14.182
a. Dependent Variable: Measure.
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(control group). Patients had been blinded to the type of
treatment they had received in the original study, and had
not at any point in time, received any information indicat-
ing what type of treatment they had received prior to
answering the long term follow- up KI questionnaire. The
study was approved by the regional committee for medical
research ethics.
The validated KI that had in the original RCT been
established at baseline, at the end of treatment, and
12 weeks post-treatment, was filled out by patients 24
(+/−2) months later. The KI incorporates 11 types of
symptoms usually associated with menopause; these in-
clude hot flashes, sweating, sleep problems, depression,
tiredness, dizziness, palpitations, joint pain, headache, va-
ginal dryness and other problems (patients must specify).
Symptoms are given a score depending on their severity,
where 0 = no symptoms and 3 = unbearable symptoms,
with a maximum score of 51. The index indicates a health
related quality of life score for those suffering from me-
nopausal symptoms either due to natural or chemically
induced causes.
Results
No significant difference in KI scores were seen at baseline
for the two groups of women. A significant improvement
in health-related quality of life (measured with KI) was ob-
served during treatment that lasted for a further 3 months
post treatment in patients receiving traditional Chinese
medical (TCM) acupuncture. There was no significant im-
provement in KI values in the sham group.
Nineteen participants did not return written statements.
A total of 61 statements were received, 33 of these women
had previously been treated with traditional Chinese acu-
puncture, and the other 28 had received sham acupunc-
ture. The mean age of the participants was 51.3 (52.5 the
TCM group and 50.2 in the control group). The women
provided their answers by mail.
In line with international guidelines, post menopausal
women switch to an aromatase antagonist after 2 years.
Twenty-eight women (12 in the TCM group and 15 in
the control group) had, during the 2 year gap between
the time they finished treatment and the time they made
their statements, switched to an aromatase antagonist.
Statistics
A mixed models procedure with diagonal covariance matrix
was used for statistical analysis. Comparison of baseline
score (time 1) between the sham group (n = 45), mean KI
15.8 and acupuncture group (n = 43), mean KI 13.4 showed
no statistically significant difference. When analyzing
differences following treatment time (time 2) (mean KI 8.4
versus mean 11.7) and after 3 months (time 3) (mean KI
10.0 versus mean 13.7), a statistically significant differencewas found. However, no such difference was found on
analyzing time 4, after 2 years (Table 1).
Pairwise comparisons at time intervals for all patients.
Group 1 - Acupuncture.
Group 2 – Sham/control (Figure 1).
At baseline: no statistically significant difference be-
tween the groups is observed (95% CI overlap for time
1- baseline).
Time 2 (end of treatment): a statistically significant
difference between the groups.
Time 3 (12 weeks post treatment): a statistically signi-
ficant difference between the groups.
Time 4 (2 years post treatment): there is no statisti-
cally significant difference between the groups.
Discussion
Our study showed lasting effect of a 10 week acupunc-
ture treatment course, measured by the KI up to 2 years
after initial treatment. To our knowledge this is the first
randomized, controlled long-term study measuring qual-
ity of life of breast cancer patients, after a series of acu-
puncture treatments. Although this study is of limited
size it supports previous RCT’s that demonstrate that
acupuncture is a safe and effective alternative to HT for
relieving vasomotor problems, and other symptoms usu-
ally associated with menopause. All patients completed
acupuncture treatment, and 76% returned questionnaires
24 months later, indicating a positive attitude to acu-
puncture in this patient group.
Wider long term effects of acupuncture were demon-
strated by using KI, extending focus beyond the main
complaint of HF, closely followed by sweating and insom-
nia; these three symptoms have been shown to affect each
other, and similarly improve simultaneously (Hervik and
Mjaland 2009; Savard and Morin 2001). The Kupperman
menopausal index has been used widely in studies of
climacteric symptoms, both in natural and chemically
induced menopause, evaluating symptom severity and
Figure 1 Shows differences in KI scores between the two groups from baseline, through treatment, up until 2 years post treatment.
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most common symptoms associated with menopause,
but has some limitations; although vaginal dryness is
measured, loss of libido, a symptom around 70% of
women taking estrogen antagonists complain of (Garreau
et al. 2006) is not. Also, unlike the menopausal rating scale
(MRS) KI is not validated according to psychometric stan-
dards, though depression is included as one of the param-
eters. Reduced cognitive function is a worrying symptom
associated with estrogen-antagonist therapy, with as many
as 46% of the 1,199 women included in a survey con-
ducted by Breast Cancer Action reported experiencing
mental fuzziness (Zivian et al. 2008). Other indexes, such
as MRS or SF36, might have provided a more comprehen-
sive demonstration of health related physiological and psy-
chological quality of life, however KI is quick and easy to
fill out possibly increasing compliance.
Although hormonal replacement therapy (HT) appears
to be the most effective treatment for HF with a rate of
around 80% efficacy in healthy women (Albertazzi 2007),
the use of HT is contraindicated in women with breast
cancer. Non hormonal treatments available for the manage-
ment of vasomotor symptoms associated with menopause
include clonidin, gabapetin and selective serotonin reuptake
inhibitors; adverse effects to these drugs are not un-
common, they include hypotension, cognitive disruption,headache, weight gain, nausea etc. (Hickey et al. 2008).
The use of selected serotonin reuptake inhibitors (SSRI’s),
anti-depressives used to treat both hot flashes and depres-
sion in women with breast cancer, has recently been the
focus of controversy. It has been suggested that SSRI’s can
inhibit the conversion of Tamoxifen to the anti-estrogen
endoxifen, and therefore reduce the effectiveness of
Tamoxifen in patients taking both drugs (Stearns et al.
2003; Goetz et al. 2007).
During menopause low levels of estrogen and high
levels of follicular stimulating hormone (FSH) are related
to vasomotor symptoms in healthy women. To be a safe
treatment acupuncture should not increase levels of
estrogen in women with ER+ breast cancer. A study by
Dong demonstrated that there was no increase in estrogen
in patients treated with acupuncture (Dong et al. 2001).
This finding was confirmed by Liljegren who found no
significant differences in hormone levels in blood, includ-
ing FSH and estradiol, in a study comparing the effect of
true acupuncture to sham in 84 Tamoxifen medicated
breast cancer patients with HF (Liljegren et al. 2012).
Hormone levels were tested at baseline and one week after
the end of five weeks of treatment.
The HABITS study (Holmberg et al. 2004) randomized
434 women with previous breast cancer to either HRT or
best treatment without hormones; the study was stopped
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cancer event compared to 7 women in the non HRT-
group, when 345 of the participants were followed up after
2 years. Treatment in the non-HRT group included
electro-acupuncture which proved to be less effective that
hormonal therapy in the reduction of HF, though more ef-
fective than placebo long-term. Since a higher recurrence
rate of breast cancer in the HRT group was observed acu-
puncture appears to be a safer treatment option.
If acupuncture has the potential to influence thermo-
regulation via the stimulation of neurotransmitters, pro-
viding not only short-term, but also a long-term reduction
in the amount of HF, it provides a viable alternative to
hormone therapy and other non-hormonal drugs that are
not without side-effects. Acupuncture is a cheap alterna-
tive, and is relatively safe when carried out by a qualified
practitioner. Furthermore since HF have been shown to
have a profound influence on sleep patterns, treatments
that indirectly affect sleep may provide a better quality of
life; possibly an explanation as to why acupuncture treat-
ment was effective for up to two years. The resulting
reduction of HF and establishment of better sleep patterns
after acupuncture may have provided patients with a
higher quality rehabilitation period, less tired and more
able to contribute to work and family commitments. Psy-
chological anxiety and depression are common symptoms
among breast cancer patients for years after diagnosis
and treatment, often these psychological symptoms are
accompanied by sleep problems (Montazeri 2008). This
invites speculation that less fatigued patients may possibly
experience a reduced amount of psychological symptoms,
and have enough energy to deal with other side-effects as-
sociated with estrogen-antagonist therapy.
Symptoms that often accompany HF such as sweating,
dizziness, palpitations and nausea, leave women feeling
less confident about their appearance in public, and anx-
ious about the possibility of stressful situations that often
provoke HF. Treatments such as acupuncture, designed
to reduce HF and thereby the likelihood of running
make-up, sweat soaked hair and clothes, and the fear of
body odor, can interrupt a vicious cycle of anxiety and
stress which in turn provoking even more vasomotor
symptoms.
Side-effects of estrogen-antagonists can lead to discon-
tinuation of anti-estrogen medication; an action which
could have serious consequences. Non hormonal treat-
ments are needed to effectively reduce at least some of
these symptoms; acupuncture is a viable treatment method.
This study has demonstrated that the long term effect of
acupuncture decreases with time, from around 12 weeks
post-treatment, it is not significant two years post-treat-
ment. Although differences between the group receiving
TCM acupuncture and those receiving sham after two
years are not significant, the effect of treatment may still bepresent, but can have lost statistical significance due to
limited sample size.
Conclusion
Previous RCT’s have indicated that acupuncture reduces
hot flashes, and betters life quality for up to three months
post-treatment in women with breast cancer. This study
suggests that these effects may be longer-term, however
they were not significant 24 months after treatment.
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